WallStSmart
SLDB

Solid Biosciences LLC

NASDAQ: SLDB · HEALTHCARE · BIOTECHNOLOGY

$7.26
+2.98% today

Updated 2026-04-30

Market cap
$733.18M
P/E ratio
P/S ratio
3.65x
EPS (TTM)
$-1.99
Dividend yield
52W range
$2 – $9
Volume
1.3M

Solid Biosciences LLC (SLDB) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$3.33M$13.62M$8.09M$0.00$0.00$0.00
Revenue growth (YoY)+308.4%-40.6%-100.0%
Cost of revenue$0.00$56000.00$448000.00$1.57M$2.82M$3.92M$2.96M$2.41M$2.58M$2.46M$1.64M
Gross profit$0.00$-56000.00$-448000.00$-1.57M$-2.82M$-3.92M$13.62M$8.09M$-2.58M$-2.46M$-1.64M
Gross margin-117.6%100.0%100.0%
R&D$4.19M$20.12M$39.91M$57.97M$94.74M$64.88M$58.74M$78.42M$76.56M$96.43M$140.32M
SG&A$2.37M$5.46M$14.95M$17.72M$24.58M$21.58M$27.14M$28.95M$27.75M$33.30M$38.88M
Operating income$-6.56M$-25.58M$-54.86M$-75.69M$-119.32M$-86.46M$-72.25M$-106.45M$-104.31M$-129.73M$-179.21M
Operating margin-2592.6%-530.5%-1315.2%
EBITDA$-6.56M$-25.52M$-54.41M$-74.12M$-116.49M$-84.37M$-69.29M$-96.87M$-93.43M$-121.90M$-177.57M
EBITDA margin-2529.8%-508.7%-1196.8%
EBIT$-6.56M$-25.58M$-54.86M$-75.69M$-119.32M$-88.29M$-72.25M$-99.27M$-96.02M$-124.36M$-179.21M
Interest expense$0.00$0.00$0.00$0.00$0.00$0.00$66000.00$20.47M$440000.00$340000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-6.38M$-21.54M$-52.12M$-74.80M$-117.22M$-88.29M$-72.19M$-85.98M$-96.02M$-124.70M$-174.32M
Net income growth (YoY)-237.8%-142.0%-43.5%-56.7%+24.7%+18.2%-19.1%-11.7%-29.9%-39.8%
Profit margin-2647.4%-530.0%-1062.3%